William J. Sandborn

Researcher Next ID · RN-001255

Researcher · Biochemistry, Genetics and Molecular Biology

San Diego, United States

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Immunology and Microbiology

Inflammatory Bowel Disease

Microscopic Colitis

Autoimmune and Inflammatory Disorders

Biosimilars and Bioanalytical Methods

Eosinophilic Esophagitis

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2020.12.031
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215734
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215739
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0904492
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050516

No projects listed.